Change search
ReferencesLink to record
Permanent link

Direct link
Truncating CHRNG mutations associated with interfamilial variability of the severity of the Escobar variant of multiple pterygium syndrome
Kariminejad-Najmabadi Pathology & Genetics Centre, Tehran, Iran.
Kariminejad-Najmabadi Pathology & Genetics Centre, Tehran, Iran.
Mehrgan Genetics Centre, Sari, Iran.
University of Skövde, School of Bioscience. University of Skövde, The Systems Biology Research Centre. (Bioinformatik, Bioinformatics)ORCID iD: 0000-0001-6254-4335
Show others and affiliations
2016 (English)In: BMC Genetics, ISSN 1471-2156, E-ISSN 1471-2156, Vol. 17, no 1, 71Article in journal (Refereed) Published
Abstract [en]

BACKGROUND:In humans, muscle-specific nicotinergic acetylcholine receptor (AChR) is a transmembrane protein with five different subunits, coded by CHRNA1, CHRNB, CHRND and CHRNG/CHRNE. The gamma subunit of AChR encoded by CHRNG is expressed during early foetal development, whereas in the adult, the γ subunit is replaced by a ε subunit. Mutations in the CHRNG encoding the embryonal acetylcholine receptor may cause the non-lethal Escobar variant (EVMPS) and lethal form (LMPS) of multiple pterygium syndrome. The MPS is a condition characterised by prenatal growth failure with pterygium and akinesia leading to muscle weakness and severe congenital contractures, as well as scoliosis.

RESULTS:Our whole exome sequencing studies have identified one novel and two previously reported homozygous mutations in CHRNG in three families affected by non-lethal EVMPS. The mutations consist of deletion of two nucleotides, cause a frameshift predicted to result in premature termination of the foetally expressed gamma subunit of the AChR.

CONCLUSIONS:Our data suggest that severity of the phenotype varies significantly both within and between families with MPS and that there is no apparent correlation between mutation position and clinical phenotype. Although individuals with CHRNG mutations can survive, there is an increased frequency of abortions and stillbirth in their families. Furthermore, genetic background and environmental modifiers might be of significance for decisiveness of the lethal spectrum, rather than the state of the mutation per se. Detailed clinical examination of our patients further indicates the changing phenotype from infancy to childhood.

Place, publisher, year, edition, pages
BioMed Central, 2016. Vol. 17, no 1, 71
Keyword [en]
severe genetic disorder
National Category
Clinical Medicine
Research subject
Medical sciences
URN: urn:nbn:se:his:diva-12337DOI: 10.1186/s12863-016-0382-5ISI: 000377077500001PubMedID: 27245440ScopusID: 2-s2.0-84971537060OAI: oai:DiVA.org:his-12337DiVA: diva2:934036
Swedish Research Council
Available from: 2016-06-08 Created: 2016-06-08 Last updated: 2016-08-17Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Olsson, BjörnTajsharghi, Homa
By organisation
School of BioscienceThe Systems Biology Research Centre
In the same journal
BMC Genetics
Clinical Medicine

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 341 hits
ReferencesLink to record
Permanent link

Direct link